Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,270 publicly listed stocks with a combined market cap of $1.89 Trillion. ASYMCHEM LAB.(TIAN.)H YC1 leads the sector with a market cap of $328.67 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.89 Trillion
Companies Listed
1,270
Largest Company
ASYMCHEM LAB.(TIAN.)H YC1
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 451 |
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90 |
$328.67 Million | €281.13 Million | Germany | €10.10 | +4.66% | +3.59% | 0.00 |
| 452 |
Jilin Jian Yisheng Pharmaceutical Co Ltd
SHE:002566 |
$328.35 Million | CN¥2.24 Billion | China | CN¥6.78 | +1.19% | -0.44% | 133.01 Million |
| 453 |
Altimmune Inc
NASDAQ:ALT |
$326.85 Million | $326.85 Million | USA | $2.61 | +0.77% | -10.62% | 66.01 Million |
| 454 |
Green Cross
KO:005250 |
$326.13 Million | ₩481.25 Billion | Korea | ₩10710.00 | -5.64% | -2.10% | 18.95 Million |
| 455 |
CHECKPOINT THER. DL-0001
F:CZTA |
$325.84 Million | €278.71 Million | Germany | €3.76 | +0.00% | +0.00% | 3.33K |
| 456 |
Greenwich Lifesciences Inc
NASDAQ:GLSI |
$324.54 Million | $324.54 Million | USA | $24.06 | +4.47% | +1.65% | 3.63 Million |
| 457 |
Verastem Inc
NASDAQ:VSTM |
$322.50 Million | $322.50 Million | USA | $4.10 | +4.06% | +6.22% | 53.30 Million |
| 458 |
Vicore Pharma Holding AB (publ)
ST:VICO |
$320.54 Million | Skr2.98 Billion | Sweden | Skr10.58 | +2.32% | +0.19% | 18.00 Million |
| 459 |
Clinuvel Pharmaceuticals Ltd
AU:CUV |
$319.70 Million | AU$451.83 Million | Australia | AU$8.96 | +1.24% | +1.47% | 1.86 Million |
| 460 |
Regenxbio Inc
NASDAQ:RGNX |
$316.91 Million | $316.91 Million | USA | $6.66 | +6.05% | -3.20% | 46.82 Million |
| 461 |
NEWRON PHARMACEUT. EO-20
F:NP5 |
$316.25 Million | €270.50 Million | Germany | €13.15 | +4.78% | +1.54% | 0.00 |
| 462 |
Silence Therapeutics PLC
NASDAQ:SLN |
$316.00 Million | $316.00 Million | USA | $6.69 | +0.15% | -2.34% | 5.05 Million |
| 463 |
Viva Biotech Holdings
F:VB0 |
$315.92 Million | €270.22 Million | Germany | €0.13 | +0.00% | -2.29% | 0.00 |
| 464 |
Lyell Immunopharma Inc
NASDAQ:LYEL |
$314.93 Million | $314.93 Million | USA | $13.50 | -1.60% | +3.45% | 2.54 Million |
| 465 |
Abeona Therapeutics Inc
NASDAQ:ABEO |
$314.56 Million | $314.56 Million | USA | $5.53 | +0.00% | -4.98% | 24.62 Million |
| 466 |
Dishman Carbogen Amcis Limited
NSE:DCAL |
$313.07 Million | Rs28.95 Billion | India | Rs184.64 | +4.65% | -3.80% | 20.08 Million |
| 467 |
Fennec Pharmaceuticals Inc
NASDAQ:FENC |
$311.94 Million | $311.94 Million | USA | $9.00 | +1.69% | -1.75% | 8.91 Million |
| 468 |
Eupraxia Pharmaceuticals Inc
TO:EPRX |
$309.59 Million | CA$427.98 Million | Canada | CA$8.45 | +0.36% | -6.42% | 1.37 Million |
| 469 |
Keros Therapeutics Inc
NASDAQ:KROS |
$309.23 Million | $309.23 Million | USA | $10.15 | +1.00% | -5.76% | 7.24 Million |
| 470 |
NEWRON PHARMACEUT. EO-20
XETRA:NP5 |
$306.87 Million | €262.49 Million | Germany | €13.15 | +0.77% | -6.41% | 101.13K |
| 471 |
Armata Pharmaceuticals Inc
NYSE MKT:ARMP |
$306.77 Million | $306.77 Million | USA | $8.36 | +1.58% | +1.95% | 1.95 Million |
| 472 |
DiaMedica Therapeutics Inc
NASDAQ:DMAC |
$304.44 Million | $304.44 Million | USA | $5.65 | +3.48% | -3.25% | 3.79 Million |
| 473 |
Scpharmaceuticals Inc
NASDAQ:SCPH |
$304.36 Million | $304.36 Million | USA | $5.67 | +0.00% | +0.35% | 42.79 Million |
| 474 |
Rezolute Inc
NASDAQ:RZLT |
$303.36 Million | $303.36 Million | USA | $4.00 | +3.63% | -11.31% | 40.39 Million |
| 475 |
Neumora Therapeutics, Inc.
NASDAQ:NMRA |
$302.49 Million | $302.49 Million | USA | $1.78 | +0.00% | +1.71% | 24.04 Million |
| 476 |
CLINUVEL PHARMAC.ADRS1
F:UR9A |
$302.25 Million | €258.53 Million | Germany | €5.15 | +0.98% | -2.83% | 924.00 |
| 477 |
Cybin Inc
NEO:CYBN |
$301.37 Million | CA$416.62 Million | Canada | CA$8.35 | -27.89% | -22.40% | 402.95K |
| 478 |
Rocket Pharmaceuticals Inc
NASDAQ:RCKT |
$300.28 Million | $300.28 Million | USA | $2.75 | +3.38% | -5.82% | 57.26 Million |
| 479 |
Cabio Biotech Wuhan Co Ltd
SHG:688089 |
$300.23 Million | CN¥2.05 Billion | China | CN¥12.19 | +0.58% | -2.09% | 73.49 Million |
| 480 |
Lineage Cell Therapeutics Inc
NYSE MKT:LCTX |
$299.43 Million | $299.43 Million | USA | $1.30 | -1.52% | -0.76% | 31.72 Million |
| 481 |
Shanghai Hile Bio-tech
SHG:603718 |
$297.63 Million | CN¥2.03 Billion | China | CN¥3.12 | -0.64% | -8.24% | 335.41 Million |
| 482 |
Newron Pharmaceuticals SpA
SW:NWRN |
$297.11 Million | CHF235.00 Million | Switzerland | CHF12.06 | -0.33% | -5.49% | 1.39 Million |
| 483 |
Palisade Bio Inc
NASDAQ:PALI |
$296.82 Million | $296.82 Million | USA | $1.71 | -3.93% | -11.40% | 61.59 Million |
| 484 |
Tenax Therapeutics Inc
NASDAQ:TENX |
$295.90 Million | $295.90 Million | USA | $11.48 | +6.99% | +3.52% | 16.86 Million |
| 485 |
NervGen Pharma Corp
V:NGEN |
$295.10 Million | CA$407.94 Million | Canada | CA$5.15 | +0.00% | -8.20% | 1.13 Million |
| 486 |
Crescent Biopharma, Inc.
NASDAQ:CBIO |
$292.50 Million | $292.50 Million | USA | $17.92 | -2.29% | -2.87% | 6.36 Million |
| 487 |
Guiyang Xintian Pharmaceutical Co Ltd
SHE:002873 |
$290.40 Million | CN¥1.98 Billion | China | CN¥8.13 | +0.87% | -1.57% | 150.82 Million |
| 488 |
Opus Genetics, Inc.
NASDAQ:IRD |
$288.47 Million | $288.47 Million | USA | $4.04 | +3.32% | -12.93% | 20.59 Million |
| 489 |
ABEONA THERAPEUT. DL-01
F:PCJ |
$283.22 Million | €242.25 Million | Germany | €4.67 | +2.73% | -2.02% | 16.07K |
| 490 |
Eledon Pharmaceuticals Inc
NASDAQ:ELDN |
$275.56 Million | $275.56 Million | USA | $3.57 | +0.00% | -0.83% | 25.05 Million |
| 491 |
Niagen Bioscience, Inc.
NASDAQ:NAGE |
$275.33 Million | $275.33 Million | USA | $3.45 | +0.58% | -1.43% | 22.20 Million |
| 492 |
Jiangsu GDK Biotechnology Co Ltd
SHG:688670 |
$273.49 Million | CN¥1.87 Billion | China | CN¥15.17 | +1.95% | -2.00% | 51.75 Million |
| 493 |
Avalo Therapeutics Inc
NASDAQ:AVTX |
$273.25 Million | $273.25 Million | USA | $14.76 | +7.97% | +8.45% | 36.42 Million |
| 494 |
Surrozen Inc
NASDAQ:SRZN |
$271.57 Million | $271.57 Million | USA | $23.39 | +0.09% | -4.06% | 2.16 Million |
| 495 |
Immuneering Corp
NASDAQ:IMRX |
$270.55 Million | $270.55 Million | USA | $4.19 | +1.70% | -6.47% | 50.21 Million |
| 496 |
Zentalis Pharmaceuticals Llc
NASDAQ:ZNTL |
$266.95 Million | $266.95 Million | USA | $3.75 | +6.53% | -3.10% | 22.81 Million |
| 497 |
2Seventy Bio Inc
NASDAQ:TSVT |
$266.14 Million | $266.14 Million | USA | $5.00 | +0.00% | +0.00% | 0.00 |
| 498 |
ANTENGENE CORP. DL-0001
F:722 |
$265.70 Million | €227.26 Million | Germany | €0.37 | +4.49% | +2.76% | 0.00 |
| 499 |
Inozyme Pharma Inc
NASDAQ:INZY |
$258.25 Million | $258.25 Million | USA | $4.00 | +0.00% | +0.25% | 12.56 Million |
| 500 |
PharmaEngine
TWO:4162 |
$257.10 Million | NT$8.16 Billion | Taiwan | NT$57.60 | +0.35% | +3.41% | 12.34 Million |
| 501 |
OmniAb Inc.
NASDAQ:OABI |
$254.80 Million | $254.80 Million | USA | $2.27 | -2.99% | -14.66% | 17.28 Million |
| 502 |
Entrada Therapeutics Inc
NASDAQ:TRDA |
$246.90 Million | $246.90 Million | USA | $6.46 | +2.38% | -7.71% | 9.73 Million |
| 503 |
SILENCE THERAP. SP.ADR/1
F:XRP2 |
$245.62 Million | €210.09 Million | Germany | €7.00 | +10.24% | +40.56% | 5.48K |
| 504 |
Foghorn Therapeutics Inc
NASDAQ:FHTX |
$244.87 Million | $244.87 Million | USA | $4.18 | +2.96% | +11.76% | 4.09 Million |
| 505 |
Editas Medicine Inc
NASDAQ:EDIT |
$244.77 Million | $244.77 Million | USA | $2.50 | +2.46% | -16.39% | 70.22 Million |
| 506 |
Genfit S.A.
NASDAQ:GNFT |
$244.43 Million | $244.43 Million | USA | $5.97 | +0.00% | -3.71% | 49.82K |
| 507 |
Shattuck Labs Inc
NASDAQ:STTK |
$244.26 Million | $244.26 Million | USA | $4.94 | +18.18% | +2.92% | 22.34 Million |
| 508 |
Santhera Pharmaceuticals Holding AG
SW:SANN |
$243.45 Million | CHF192.56 Million | Switzerland | CHF15.60 | +0.39% | -11.86% | 1.80 Million |
| 509 |
Third Harmonic Bio Inc.
NASDAQ:THRD |
$242.79 Million | $242.79 Million | USA | $5.38 | +0.00% | +0.00% | 4.38 Million |
| 510 |
Zura Bio Limited Class A Ordinary Shares
NASDAQ:ZURA |
$240.59 Million | $240.59 Million | USA | $3.70 | +3.35% | +0.82% | 19.93 Million |
| 511 |
Sol Gel Technologies Ltd
NASDAQ:SLGL |
$240.07 Million | $240.07 Million | USA | $73.44 | -2.47% | -1.25% | 871.52K |
| 512 |
Tiansheng Pharmaceutical Group Co Ltd
SHE:002872 |
$239.18 Million | CN¥1.63 Billion | China | CN¥5.14 | +2.39% | -2.10% | 91.52 Million |
| 513 |
Orchestra BioMed Holdings Inc.
NASDAQ:OBIO |
$238.92 Million | $238.92 Million | USA | $4.10 | +0.74% | +2.76% | 6.18 Million |
| 514 |
SillaJen Inc
KQ:215600 |
$238.70 Million | ₩352.23 Billion | Korea | ₩2550.00 | +0.99% | -5.56% | 20.12 Million |
| 515 |
ADAGENE INC. SP.ADR
F:978 |
$237.92 Million | €203.50 Million | Germany | €3.08 | -2.53% | -2.53% | 3.31K |
| 516 |
Adagene Inc
NASDAQ:ADAG |
$235.88 Million | $235.88 Million | USA | $3.57 | -0.28% | -0.28% | 3.83 Million |
| 517 |
AC Immune Ltd
NASDAQ:ACIU |
$235.10 Million | $235.10 Million | USA | $2.31 | +2.21% | -3.75% | 7.55 Million |
| 518 |
Cellectis
PA:ALCLS |
$234.57 Million | €200.64 Million | France | €2.76 | +0.29% | +2.75% | 7.62 Million |
| 519 |
Adimmune Corp
TW:4142 |
$234.39 Million | NT$7.44 Billion | Taiwan | NT$17.65 | +0.28% | -0.84% | 32.62 Million |
| 520 |
Humacyte Inc
NASDAQ:HUMA |
$234.23 Million | $234.23 Million | USA | $1.06 | -2.31% | -29.19% | 205.59 Million |
| 521 |
SAB Biotherapeutics Inc
NASDAQ:SABS |
$234.02 Million | $234.02 Million | USA | $3.33 | -1.48% | -4.03% | 12.94 Million |
| 522 |
Cybin Inc. Common Stock
NYSE MKT:HELP |
$233.50 Million | $233.50 Million | USA | $4.68 | +1.74% | -7.51% | 27.65 Million |
| 523 |
ProKidney Corp.
NASDAQ:PROK |
$232.86 Million | $232.86 Million | USA | $1.64 | -1.20% | -11.35% | 24.12 Million |
| 524 |
Anavex Life Sciences Corp
NASDAQ:AVXL |
$231.68 Million | $231.68 Million | USA | $2.50 | +0.00% | -11.35% | 27.98 Million |
| 525 |
Nuvectis Pharma Inc
NASDAQ:NVCT |
$231.56 Million | $231.56 Million | USA | $10.71 | +1.90% | +10.75% | 2.45 Million |
| 526 |
Nautilus Biotechnology Inc
NASDAQ:NAUT |
$231.14 Million | $231.14 Million | USA | $2.24 | -1.97% | -16.42% | 10.96 Million |
| 527 |
ACELYRIN, INC. Common Stock
NASDAQ:SLRN |
$229.17 Million | $229.17 Million | USA | $2.27 | +0.00% | +0.00% | 0.00 |
| 528 |
Egetis Therapeutics AB (publ)
ST:EGTX |
$228.33 Million | Skr2.12 Billion | Sweden | Skr5.33 | +1.14% | -10.12% | 19.29 Million |
| 529 |
Fulcrum Therapeutics Inc
NASDAQ:FULC |
$227.60 Million | $227.60 Million | USA | $3.45 | -2.82% | +2.37% | 69.26 Million |
| 530 |
Invivyd Inc.
NASDAQ:IVVD |
$226.85 Million | $226.85 Million | USA | $0.77 | -5.23% | -30.63% | 97.42 Million |
| 531 |
Cellectis SA
NASDAQ:CLLS |
$224.37 Million | $224.37 Million | USA | $3.09 | +0.00% | -1.90% | 1.12 Million |
| 532 |
AC IMMUNE SA SF-02
F:IMR |
$222.02 Million | €189.91 Million | Germany | €1.87 | +5.54% | -5.76% | 0.00 |
| 533 |
Protara Therapeutics Inc
NASDAQ:TARA |
$219.20 Million | $219.20 Million | USA | $3.90 | +6.85% | -11.56% | 18.88 Million |
| 534 |
MacroGenics Inc
NASDAQ:MGNX |
$218.65 Million | $218.65 Million | USA | $3.96 | -1.25% | -6.82% | 32.11 Million |
| 535 |
CAMP4 THERAPEUTICS CORPORATION
NASDAQ:CAMP |
$217.57 Million | $217.57 Million | USA | $4.19 | -0.71% | -2.56% | 2.01 Million |
| 536 |
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX |
$216.19 Million | $216.19 Million | USA | $4.47 | +0.00% | +0.22% | 47.39 Million |
| 537 |
Tetratherix Ltd
AU:TTX |
$215.52 Million | AU$304.59 Million | Australia | AU$6.00 | +14.29% | -4.76% | 641.98K |
| 538 |
Oryzon Genomics SA
MC:ORY |
$214.95 Million | €183.86 Million | Spain | €3.14 | +0.71% | +3.63% | 12.13 Million |
| 539 |
Zhuhai Sailong Pharmaceutical Co Ltd
SHE:002898 |
$213.76 Million | CN¥1.46 Billion | China | CN¥8.30 | -5.03% | -26.48% | 30.41 Million |
| 540 |
Transgene SA
PA:TNG |
$213.47 Million | €182.59 Million | France | €0.77 | -0.13% | -1.91% | 1.06 Million |
| 541 |
LENZ Therapeutics Inc
NASDAQ:LENZ |
$212.27 Million | $212.27 Million | USA | $6.77 | +4.15% | -5.97% | 18.66 Million |
| 542 |
Minerva Neurosciences Inc
NASDAQ:NERV |
$210.12 Million | $210.12 Million | USA | $4.51 | -2.38% | -5.65% | 3.25 Million |
| 543 |
Coherus BioSciences Inc
NASDAQ:CHRS |
$209.85 Million | $209.85 Million | USA | $1.40 | -1.41% | -11.11% | 31.25 Million |
| 544 |
Alx Oncology Holdings
NASDAQ:ALXO |
$207.23 Million | $207.23 Million | USA | $1.58 | +3.95% | +1.28% | 24.03 Million |
| 545 |
Genomictree Inc.
KQ:228760 |
$205.08 Million | ₩302.61 Billion | Korea | ₩12600.00 | +2.69% | +2.61% | 3.01 Million |
| 546 |
Circio Holding ASA
OL:CRNA |
$204.25 Million | Nkr1.94 Billion | Norway | Nkr8.16 | +9.09% | -2.86% | 186.33 Million |
| 547 |
Bicycle Therapeutics plc
F:50BA |
$202.59 Million | €173.28 Million | Germany | €3.44 | +0.58% | -3.37% | 780.00 |
| 548 |
Starpharma Holdings Ltd
AU:SPL |
$202.53 Million | AU$286.23 Million | Australia | AU$0.68 | +1.49% | -9.33% | 35.85 Million |
| 549 |
Atrys Health SL
MC:ATRY |
$202.32 Million | €173.06 Million | Spain | €2.66 | -0.37% | -5.34% | 1.43 Million |
| 550 |
Bicycle Therapeutics Ltd
NASDAQ:BCYC |
$202.22 Million | $202.22 Million | USA | $4.05 | -1.22% | -5.15% | 7.98 Million |
| 551 |
Onward Medical N.V.
BR:ONWD |
$200.59 Million | €171.58 Million | Belgium | €2.63 | -0.94% | -8.54% | 3.84 Million |
| 552 |
GENFIT S.A. ADR/1 EO-25
F:XUPB |
$200.59 Million | €171.58 Million | Germany | €5.90 | -4.07% | +9.26% | 252.00 |
| 553 |
Karyopharm Therapeutics Inc
NASDAQ:KPTI |
$198.68 Million | $198.68 Million | USA | $9.50 | +5.56% | +4.74% | 11.18 Million |
| 554 |
Taigen Biopharmaceuticals Holdings Ltd
TWO:4157 |
$198.25 Million | NT$6.29 Billion | Taiwan | NT$8.84 | +2.79% | -2.10% | 38.15 Million |
| 555 |
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT |
$198.11 Million | $198.11 Million | USA | $6.97 | +0.00% | -13.31% | 10.29 Million |
| 556 |
Voyager Therapeutics Inc
NASDAQ:VYGR |
$194.60 Million | $194.60 Million | USA | $3.50 | +1.16% | -3.31% | 13.81 Million |
| 557 |
Savior Lifetec
TWO:4167 |
$194.15 Million | NT$6.16 Billion | Taiwan | NT$19.85 | +1.02% | -3.41% | 26.32 Million |
| 558 |
Unicycive Therapeutics Inc
NASDAQ:UNCY |
$193.58 Million | $193.58 Million | USA | $7.25 | -5.72% | -2.42% | 18.26 Million |
| 559 |
NervGen Pharma Corp.
NASDAQ:NGEN |
$192.23 Million | $192.23 Million | USA | $1.92 | +1.59% | -4.48% | 32.00 Million |
| 560 |
Atrium Therapeutics, Inc. Common Stock
NASDAQ:RNA |
$191.92 Million | $191.92 Million | USA | $12.37 | -0.48% | +0.57% | 4.65 Million |
| 561 |
Saniona AB
ST:SANION |
$191.77 Million | Skr1.78 Billion | Sweden | Skr12.91 | -1.07% | -5.07% | 11.97 Million |
| 562 |
ONWARD MEDICAL BV EO -12
F:63E |
$191.55 Million | €163.84 Million | Germany | €2.58 | -1.53% | -3.73% | 0.00 |
| 563 |
Sinphar Pharmaceutical Co Ltd
TW:1734 |
$188.76 Million | NT$5.99 Billion | Taiwan | NT$31.50 | +1.29% | +0.48% | 9.85 Million |
| 564 |
SOL-GEL TECHN. IS-10
F:4SG |
$188.23 Million | €161.00 Million | Germany | €61.50 | +6.96% | +0.00% | 1.51K |
| 565 |
Canton Strategic Holdings, Inc.
NASDAQ:CNTN |
$187.08 Million | $187.08 Million | USA | $3.09 | +2.32% | +26.12% | 18.84 Million |
| 566 |
Elicio Therapeutics Inc.
NASDAQ:ELTX |
$185.36 Million | $185.36 Million | USA | $14.85 | +6.53% | +6.60% | 3.62 Million |
| 567 |
Mediwound Ltd
NASDAQ:MDWD |
$182.52 Million | $182.52 Million | USA | $14.22 | +0.92% | -1.59% | 2.49 Million |
| 568 |
Biomm S.A
SA:BIOM3 |
$179.90 Million | R$916.84 Million | Brazil | R$6.70 | -2.33% | -1.47% | 5.52 Million |
| 569 |
Nkarta Inc
NASDAQ:NKTX |
$179.58 Million | $179.58 Million | USA | $2.86 | +3.62% | +3.25% | 13.58 Million |
| 570 |
MediWound Ltd
F:M8W |
$176.08 Million | €150.61 Million | Germany | €12.70 | +3.25% | +7.63% | 60.00 |
| 571 |
Cartesian Therapeutics Inc.
NASDAQ:RNAC |
$172.18 Million | $172.18 Million | USA | $9.51 | +17.99% | +45.19% | 8.77 Million |
| 572 |
Forte Biosciences Inc
NASDAQ:FBRX |
$172.07 Million | $172.07 Million | USA | $17.56 | +0.92% | +5.21% | 6.14 Million |
| 573 |
Galectin Therapeutics Inc
NASDAQ:GALT |
$171.89 Million | $171.89 Million | USA | $2.67 | +2.30% | +12.18% | 7.93 Million |
| 574 |
NovaBridge Biosciences
NASDAQ:NBP |
$171.78 Million | $171.78 Million | USA | $1.49 | +1.36% | -17.22% | 16.62 Million |
| 575 |
BioInvent International AB
ST:BINV |
$171.37 Million | Skr1.59 Billion | Sweden | Skr24.20 | -2.42% | -21.17% | 5.68 Million |
| 576 |
Kangstem Biotech Co. Ltd
KQ:217730 |
$170.82 Million | ₩252.07 Billion | Korea | ₩2680.00 | -0.56% | -0.56% | 18.71 Million |
| 577 |
SANIONA AB (PUBL)
F:30S |
$170.61 Million | €145.93 Million | Germany | €1.16 | +3.19% | -5.98% | 500.00 |
| 578 |
I-MAB SPONS.ADS/1 -0001
F:0VY |
$169.01 Million | €144.56 Million | Germany | €1.25 | -3.85% | -15.54% | 316.00 |
| 579 |
KNOTUS Co.Ltd
KQ:278650 |
$168.87 Million | ₩249.19 Billion | Korea | ₩2950.00 | -1.34% | -5.30% | 5.03 Million |
| 580 |
Alector Inc
NASDAQ:ALEC |
$168.85 Million | $168.85 Million | USA | $1.53 | -2.55% | -15.47% | 17.17 Million |
| 581 |
Mycenax Biotech
TWO:4726 |
$165.57 Million | NT$5.26 Billion | Taiwan | NT$25.35 | +2.22% | -7.99% | 7.55 Million |
| 582 |
Korro Bio, Inc.
NASDAQ:KRRO |
$165.28 Million | $165.28 Million | USA | $11.61 | +10.26% | +3.85% | 3.36 Million |
| 583 |
Molecular Partners AG ADR
NASDAQ:MOLN |
$164.56 Million | $164.56 Million | USA | $4.40 | +1.38% | +4.76% | 66.47K |
| 584 |
Panion & BF Biotech Inc
TW:1760 |
$162.35 Million | NT$5.15 Billion | Taiwan | NT$60.10 | +1.01% | -1.80% | 5.08 Million |
| 585 |
Bioversys AG
SW:BIOV |
$161.41 Million | CHF127.67 Million | Switzerland | CHF26.20 | +0.00% | -2.60% | 29.07K |
| 586 |
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP |
$161.23 Million | $161.23 Million | USA | $11.35 | +6.57% | -4.46% | 12.78 Million |
| 587 |
AN2 Therapeutics Inc
NASDAQ:ANTX |
$160.54 Million | $160.54 Million | USA | $4.74 | +6.52% | +13.67% | 5.34 Million |
| 588 |
Immunic Inc
NASDAQ:IMUX |
$158.42 Million | $158.42 Million | USA | $13.86 | +6.04% | -3.95% | 5.99 Million |
| 589 |
Precision BioSciences Inc
NASDAQ:DTIL |
$157.39 Million | $157.39 Million | USA | $6.10 | -1.13% | -4.84% | 8.47 Million |
| 590 |
Turn Therapeutics Inc. Common Stock
NASDAQ:TTRX |
$157.28 Million | $157.28 Million | USA | $6.05 | +3.16% | +5.22% | 1.45 Million |
| 591 |
Sensorion SA
PA:ALSEN |
$156.43 Million | €133.80 Million | France | €0.26 | -6.64% | -32.82% | 52.39 Million |
| 592 |
Protalix Biotherapeutics Inc
NYSE MKT:PLX |
$156.31 Million | $156.31 Million | USA | $2.10 | +3.45% | +5.00% | 19.50 Million |
| 593 |
Thor Medical ASA
OL:TRMED |
$155.99 Million | Nkr1.48 Billion | Norway | Nkr4.19 | +5.68% | -0.71% | 28.87 Million |
| 594 |
Hyloris Developmentsen Sa
BR:HYL |
$155.49 Million | €133.00 Million | Belgium | €4.75 | -1.45% | -5.38% | 85.13K |
| 595 |
Acumen Pharmaceuticals Inc
NASDAQ:ABOS |
$155.29 Million | $155.29 Million | USA | $2.37 | +0.00% | +3.49% | 7.86 Million |
| 596 |
ProQR Therapeutics BV
NASDAQ:PRQR |
$151.70 Million | $151.70 Million | USA | $1.44 | +0.00% | -5.88% | 12.88 Million |
| 597 |
Oramed Pharmaceuticals Inc
NASDAQ:ORMP |
$149.38 Million | $149.38 Million | USA | $3.87 | +1.84% | +1.57% | 5.17 Million |
| 598 |
Caribou Biosciences Inc
NASDAQ:CRBU |
$149.08 Million | $149.08 Million | USA | $1.60 | -3.92% | -22.76% | 46.17 Million |
| 599 |
Theratechnologies Inc.
TO:TH |
$148.68 Million | CA$205.53 Million | Canada | CA$4.47 | -4.89% | -1.76% | 547.73K |
| 600 |
Spero Therapeutics Inc
NASDAQ:SPRO |
$147.65 Million | $147.65 Million | USA | $2.85 | +5.56% | -4.36% | 20.01 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries